CompoAtlas

PHYTOSPAGYRIE N°4 METABOLISME Glucides-Lipides-Cholestérol

Food supplement declared in France, declaration No 2020-10-917, decision dated 21 October 2020

PHYTOSPAGYRIE N°4 METABOLISME Glucides-Lipides-Cholestérol (HERBIER DU VELAY) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Chrysanthellum americanum 375 mg per day, Juglans regia 375 mg per day, Vaccinium myrtillus 375 mg per day, Olea europaea 375 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
HERBIER DU VELAY
Food business operator placing the product on the market
SAS VECTEUR ENERGY
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Bottle
Daily dose
10
Directions for use
Prendre 5ml (1cuillère à café) matin et soir, à diluer dans 5 à 10 volumes d'eau. Agiter avant utili
Objectives stated by the manufacturer (these are not authorised claims)
Antioxidant

Declaration 209202, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Chrysanthellum americanum (L.) VatkeSommités fleuriesMacérât hydroglycériné375 mg
Juglans regia L.Parties aériennesMacérât hydroglycériné375 mg
Vaccinium myrtillus L.FeuilleMacérât hydroglycériné375 mg
Olea europaea L.FeuilleMacérât hydroglycériné375 mg

Additives

E422

Other ingredients

Vin rouge

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vaccinium myrtillus L.
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

  • Olea europaea L.
    Read the warning, when it applies and the studies cited

    OLIVE LEAF - OLEA EUROPAEA

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you pregnant or breastfeeding (EMA 2017).

    Sources cited by Health Canada (1)
    • EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (EMA 2017).

    Sources cited by Health Canada (1)
    • EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other diuretics (EMA 2017).

    Sources cited by Health Canada (1)
    • EMA 2017: European Medicines Agency. European Union herbal monograph on Olea europaea L., folium. [Accessed 2024 November 27]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-olea-europaea-l-folium-first-version_en.pdf

    Known adverse reactions

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : HERBIER DU VELAY

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “PHYTOSPAGYRIE N°4 METABOLISME Glucides-Lipides-Cholestérol (HERBIER DU VELAY): composition and regulation”, https://compoatlas.com/en/supplements/products/209202-phytospagyrie-n-4-metabolisme-glucides-lipides-cholesterol, updated 15 November 2026.

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line